Dominant-negative mutants of cJun inhibit AP-1 activity through multiple mechanisms and with different potencies

Cell Growth and Differentiation

Volumn 7, Issue 8, 1996, Pages 1013-1021

  Brown, Powel H ^a,b   Kim, Sung Ho ^a   Wise, Scott C ^a   Sabichi, Anita L ^a   Birrer, Michael J ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE ZIPPER PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; DNA BINDING; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ONCOGENE C JUN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; TRANSACTIVATION;

ANIMALS; CELLS, CULTURED; DIMERIZATION; DNA-BINDING PROTEINS; GENES, RAS; MUTATION; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSFORMATION, GENETIC;

EID: 0029827772     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Johnson, P. F., and McKnight, S. L. Eukaryotic transcriptional regulatory proteins. Annu. Rev. Biochem., 58: 799-839, 1989.
2. Tjian, R., and Maniatis, T. Transcriptional activation: a complex puzzle with few easy pieces. Cell, 77: 5-8, 1994.
3. Clark, A. R., and Docherty, K. Negative regulation of transcription in eukaryotes. Biochem. J., 296: 521-541, 1993.
4. Angel, P., and Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072: 129-157, 1991.
5. Lamb, P., and McKnight, S. L. Diversity and specificity in transcriptional regulation: the benefits of heterotypic dimerization. Trends Biochem. Sci., 16: 417-422, 1991.
6. Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P., and Karin, M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated transacting factor. Cell, 49: 729-739, 1987.
7. Angel, P., Allegretto, E. A., Okino, S. T., Hattori, K., Boyle, W. J., Hunter, T., and Karin, M. Oncogene jun encodes a sequence-specific transactivator similar to AP-1. Nature (Lond.), 332: 166-171, 1988.
8. Lee, W., Haslinger, A., Karin, M., and Tjian, R. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature (Lond.), 325: 368-372, 1987.
9. Bohmann, D., Bos, T. J., Admon, A., Nishimura, T., Vogt, P. K., and Tjian, R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science (Washington DC), 238: 1386-1392, 1987.
10. Chiu, R., Boyle, W. J., Meek, J., Smeal, T., Hunter, T., and Karin, M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell, 54: 541-552, 1988.
11. Rauscher, F., III, Cohen D. R., Curran, T., Bos, T. J., Vogt, P. K., Bohmann, D., Tjian, R., and Franza, B. J. Fos-associated protein p39 is the product of the jun proto-oncogene. Science (Washington DC), 240: 1010-1016, 1988.
12. Sassone-Corsi, C. P., Lamph, W. W., Kamps, M., and Verma, I. M. Fos-associated cellular p39 is related to nuclear transcription factor AP-1. Cell, 54: 553-560, 1988.
13. McDonald, S. E., Kerr, L. D., and Matrisian, L. M. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C. Mol. Cell. Biol., 10: 4284-4293, 1990.
14. Muegge, K., Williams, T. M., Kant, J., Karin, M., Chiu, R., Schmidt, A., Siebenlist, U., Young, H. A., and Durum, S. K. lnterleukin-1 costimulatory activity on the interteukin-2 promoter via AP-1. Science (Washington DC), 246: 249-251, 1989.
15. Hofmann, M., Rudy, W., Gunthert, U., Zimmer, S. G., Zawadzki, V., Zoller, M., Lichtner, R. B., Herrlich, P., and Ponta, H. A link between ras and metastatic behavior of tumor cells: Ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer. Res., 53: 1516-1521, 1993.
16. Alani, R., Brown, P., Binetruy, B., Dosaka, H., Rosenberg, R. K., Angel, P., Karin, M., and Birrer, M. J. The transactivation domain of the cJun proto-oncoprotein is required for cotransformation of rat embryo cells. Mol. Cell. Biol., 11: 6286-6295, 1991.
17. Angel, P., Smeal, T., Meek, J., and Karin, M. Jun and v-jun contain multiple regions that participate in transcriptional activation in an interdependent manner. New Biol., 1: 35-43, 1989.
18. Bohmann, D., and Tjian, R. Biochemical analysis of transcriptional activation by Jun: differential activity of c- and v-Jun. Cell, 59: 709-717, 1989.
19. Hirai, S., Bourachot, B., and Yaniv, M. Both Jun and Fos contribute to transcription activation by the heterodimer. Oncogene, 5: 39-46, 1990.
20. Baichwal, V. R., and Tjian, R. Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain δ: differences between v-and c-Jun. Cell, 63: 815-825, 1990.
21. Abate, C., Luk, D., and Curran, T. Transcriptional regulation by fos and jun in vitro: interaction among multiple activator and regulatory domains. Mol. Cell. Biol., 11: 3624-3632, 1991.
22. Brown, P. H., Alani, R., Preis, L. H., Szabo, E., and Birrer, M. J. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene, 8: 877-886, 1993.
23. Bartel, D. P., Sheng, M., Lau, L. F., and Greenberg, M. E. Growth factors and membrane depolarization activate distinct programs of early response gene expression: dissociation of fos and jun induction. Genes Dev., 3: 304-313, 1989.
24. Domann, F. E., Levy, J. P., Birrer, M. J., and Bowden, G. T. Stable expression of a c-Jun deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth & Differ., 5: 1 9-16, 1994.
25. Dong, Z., Birrer, M. J., Watts, R. G., Matrisian, L. M., and Colburn, N. H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl. Acad. Sci. USA, 91: 609-613, 1994.
26. Cippitelli, M., Sica, A., Viggiano, V., Ye, J., Ghosh, P., Birrer, M., and Young, H. Negative transcriptional regulation of the Interferon-γ promoter by glucocorticoids and dominant negative mutants of c-Jun. J. Biol. Chem., 270: 12548-12556, 1995.
27. Lee, W., Mitchell, P., and Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell, 49: 741-752, 1987.
28. Brown, P. H., Chen, T. K., and Birrer, M. J. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene, 9: 791-800, 1994.
29. Oehler, T., and Angel, P. A common intermediary factor (p52/54) recognizing "acidic blob"-type domains is required for transcriptional activation by the Jun proteins. Mol. Cell. Biol., 12: 5508-5515, 1992.
30. Krylov, D., Olive, M., and Vinson, C. Extending dimerization interfaces: the bZIP basic region can form a coiled coil. EMBO J., 14: 5329-5337, 1995.
31. Ransone, L. J., Visvader, J., Wamsley, P., and Verma, I. M. trans-Dominant negative mutants of Fos and Jun. Proc. Natl. Acad. Sci. USA, 87: 3806-3810, 1990.
32. Smeal, T., Angel, P., Meek, J., and Karin, M. Different requirements for formation of Jun: Jun and Jun: Fos complexes. Genes Dev., 3: 2091-2100, 1989.
33. Wick, M., Lucibello, F. C., and Muller, R., Inhibition of Fos- and Ras-induced transformation by mutant Fos proteins with structural alterations in functionally different domains. Oncogene, 7: 859-867, 1992.
34. Granger-Schnarr, M., Benusiglio, E., Schnarr, M., and Sassone-Corsi, P. Transformation and transactivatior suppressor activity of the c-Jun leucine zipper fused to a bacterial repressor. Proc. Natl. Acad. Sci. USA, 89: 4236-4239, 1992.
35. Lloyd, A., Yancheva, N., and Wasylyk, B. Transformation suppressor activity of a Jun transcription factor lacking its activation domain. Nature (Lond.), 352: 635-638, 1991.
36. Rapp, U. R., Troppmairi, J., Beck, T., and Birrer, M. J. Transformation by raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative cJun mutant. Oncogene, 9: 3493-3498, 1994.
37. Nakabeppu, Y., and Nathans, D. A naturally occurring truncated form of fosb that inhibits fos/jun transcriptional activity. Cell, 64: 751-759, 1991.
38. Dobrzanski, P., Noguchi, T., Kovary, K., Risso, C. A., Lazo, P. S., and Bravo, R. Both products of the fosB gene, FosB and its short form, FosBS/F, are transcriptional activators in fibroblasts. Mol. Cell. Biol., 11: 5470-5478, 1991.
39. Mumberg, D., Lucibello, F. C., Schuermann, M., and Muller, R. Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins. Genes Dev., 5: 1212-1223, 1991.
40. Yen, J., Wisdom, R. M., Tratner, I., and Verma, I. M. An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins. Proc. Natl. Acad. Sci. USA, 88: 5077-5081, 1991.
41. Okuno, H., Suzuki, T., Yoshida, Y., Hashimoto, Y., Curran, T., and Iba, H. Inhibition of jun transformation by a mutated fos gene: design of an anti-oncogene. Oncogene, 6: 1491-1497, 1991.
42. Laemmli, E. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
43. Schutte, J., Minna, J. D., and Birrer, M. J. Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene. Proc. Natl. Acad. Sci. USA, 86: 2257-2261, 1989.
44. Franklin, C. C., McCulloch, V., and Kraft, A. S. In vitro association between the Jun protein family and the general transcription factors, TBP and TFIIB. Biochem. J., 305: 967-974, 1995.
45. Gorman, C. M., Moffat, L. F., and Howard, B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol., 2: 1044-1051, 1982.